Neurology
3 drugs are in development for Early Alzheimer's Disease.
- Companies
- 3
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Early Alzheimer's Disease pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| LEQEMBI | BIOGEN INC. (BIIB) |
Phase 2(2)
| Drug | Company |
|---|---|
| nivisnebart | Alector, Inc. (ALEC) |
| sabirnetug | Acumen Pharmaceuticals, Inc. (ABOS) |
About this indication
Early Alzheimer's Disease context
Neurology·MeSH: Alzheimer Disease (D000544)
Narrower concept of MeSH descriptor Alzheimer Disease
Frequently asked questions
How many drugs are in development for Early Alzheimer's Disease?
BioSniper tracks 3 drugs in development for Early Alzheimer's Disease across 3 companies.
How many clinical trials target Early Alzheimer's Disease?
There are 6 clinical trials targeting Early Alzheimer's Disease tracked by BioSniper.